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Background: Assessment health literacy in people with cardiovascular health problems 46 
would facilitate the development of appropriate health strategies for the care and reduction 47 
of complications associated with oral anticoagulation therapy. Aim: To evaluate the 48 
relationship between health literacy and health and treatment outcomes (concordance with 49 
oral anticoagulants, Normalized Ratio control and occurrence of complications) in patients 50 
with cardiovascular pathology. 51 
Methods: Observational, analytic and cross-sectional study carried out on 252 patients with 52 
cardiovascular pathology (atrial fibrillation, flutter or valve prosthesis), aged 50–85 years, 53 
accessing primary care services in Valencia (Spain) in 2018–2019. Variables referring to 54 
anticoagulant treatment with vitamin K antagonists (years of treatment, adequate control, 55 
polypharmacy and occurrence of complications, among others) and health literacy (Health 56 
Literacy Questionnaire) were analysed. 57 
Results: All dimensions of health literacy were significantly related to the level of 58 
education (p<0.02), social class (p<0.02), an adequate control of acenocoumarol (p<0.001), 59 
frequentation of health services (p<0.001), information by patients to health professionals 60 
about anticoagulant treatment (p<0.03), emergency care visits (p<0.001) and unscheduled 61 
hospital admissions (p<0.001).   62 
Conclusion: Health literacy has a relevant influence on the adequate self-management of 63 
anticoagulation treatment and the frequency of complications. The different dimensions 64 
that comprise health literacy play an important role, but the “social health support” 65 
dimension seems to be essential for such optimal self-management. 66 





KEYWORDS: Health Literacy, Anticoagulants, Acenocoumarol, Treatment Adherence 69 
and Compliance, Self-Management, Drug-Related Side Effects and Adverse Reaction, 70 
Health Services. 71 
 72 
BACKGROUND 73 
Cardiovascular diseases are the leading cause of death worldwide. Atrial fibrillation (AF) is 74 
the most frequent arrhythmia, associated with high mortality and morbidity1, and with an 75 
estimated prevalence in Spain of over 4.4%. Therapeutic management of AF requires 76 
modification of cardiovascular risk factors and use of drugs1,2 such as oral anticoagulants 77 
(OAC). Among these, both vitamin K antagonists (VKAs) and direct oral anticoagulants 78 
(DOACs) are effective in preventing embolic events2. Because the anticoagulant effect of 79 
DOACs is difficult to quantify, continuous monitoring and education are necessary to 80 
ensure therapeutic follow-up, reflecting the complexity of DOACs use3,4.  81 
 82 
The recommendations for switching from VKAs to DOACs due to the suboptimal control 83 
of the international normalized ratio (INR) were eased in Spain in 2012. At present, 84 
however, the legal requirement for a visa and the high financial cost of DOACs prescribing 85 
make it difficult to obtain widespread access for patients5. For such reasons, VKAs 86 
continue to be the most frequently used OAC in Spain, despite the need for routine blood 87 
tests and an exquisite clinical control6. Further, it is vital that patients demonstrate adequate 88 
self-care, along with treatment concordance and sufficient knowledge to avoid or mitigate 89 
adverse effects, to maintain the effectiveness of this treatment. 90 
 91 
With these requirements in place, health literacy (HL) could be an essential factor for the 92 




Conceptually, HL encompasses different aspects such as empowerment, as well as 94 
competencies to understand, evaluate and use health information to make decisions, 95 
including the use of health services8. Some preliminary studies exploring the effect of HL 96 
on awareness about AF and medication concordance have demonstrated that people with 97 
inadequate or insufficient levels of HL have poorer health outcomes, have less knowledge 98 
about their health problems and diseases, use preventive services less, and suffer from 99 
higher mortality9,10. 100 
 101 
So far, HL has been linked to the health conditions and outcomes of people with 102 
cardiovascular disease. Therefore, we believe that effective self-care, adherence to 103 
treatment with oral anticoagulants and prevention of complications could be directly related 104 
to the level of health literacy. 105 
 106 
However, the existing literature has directly associated higher levels of HL with greater 107 
knowledge of the disease, but the association among HL, adherence to anticoagulant 108 
therapy and the occurrence of adverse events has presented highly variable results and 109 
studies have been scarce11. 110 
 111 
Because of this, we propose identifying the level of HL in the local population on 112 
anticoagulation treatment and exploring the relationship between HL and several health and 113 
clinical outcomes. In addition, our work will provide information about the relationship 114 
between the different dimensions that make up HL, including the social dimension as a 115 







Study Design 120 
Observational, analytic and cross-sectional study. 121 
 122 
Population 123 
We focused on 6 areas within the Xàtiva/Ontinyent Health Department (Valencia, Spain), 124 
which were randomly selected from the 17 areas of the department (chose 6 numbers at 125 
random, choosing the areas that corresponded with the number extracted). During the study 126 
period (January 1, 2018 to April 30, 2019), all patients who came to the nursing 127 
consultation were invited to fill out the HL questionnaire. For a population of N = 730 128 
patients (data provided by the health department's pharmacy service), the smallest 129 
representative sample we calculated is 252 patients (confidence level 95%, margin of error 130 
5%, population proportion 50%). Recruitment ended after reaching the minimum 131 
representative study sample (because the questionnaire was long, with complex questions 132 
and patients in many cases refused to stay and wait 15-20 minutes more in the health 133 
centre). 134 
 135 
The eligibility criteria were: Patients who are between 50 and 85 years old, have 136 
cardiovascular disease, mainly arrhythmias (atrial fibrillation or flutter) or valvular disease, 137 
and have received VKAs treatment for at least 6 months. Exclusion criteria included vision 138 
or hearing impairment that prevented the completion of the HL questionnaire, illiteracy, 139 
discontinued treatment with VKAs, severe neurocognitive or mental health problems that 140 
prevented the patient from understanding their pathological conditions, and finally patients 141 
whose treatment with VKAs was administered by another person. Methods of selection of 142 




consultation (both on a scheduled and on demand) and met the selection criteria. 144 
 145 
The study was conducted in rural areas with a population of 2300 to 8000 inhabitants in 146 
each primary health care center, where the distance to the health care center is usually short 147 
and can be reached on foot by most citizens. 148 
 149 
Study Assessment Parameters 150 
Data were obtained on the following variables: 151 
- Socio-demographic: Age, sex, educational level (without studies/basic 152 
education/university education) and self-perceived social class (low/medium/high).  153 
- Clinical: Main diagnosis, obesity (BMI > 30), high blood pressure (HBP), 154 
polypharmacy (prescription ≥ 5 drugs), tobacco use (non-smoker/smoker) and 155 
occurrence of complications (emergency care or unscheduled hospital admissions 156 
during the previous six months). 157 
- VKA treatment: Years of treatment, reporting of VKA treatment by patients to other 158 
health professionals, number of controls in 6 months, control of VKA treatment 159 
[good control if ~65% INR measurements within range, with measurement by direct 160 
method, for at least 6 months] 1,2,  161 
- HL: The Health Literacy Questionnaire (HLQ) 12 was used to assess the level of HL. 162 
This questionnaire assesses 9 different dimensions, consists of 44 items and has 163 
been validated for Spanish speakers. 164 
• Dimension 1 (D1): Feeling understood and supported by health care 165 
providers. 166 
• Dimension 2 (D2): Having enough information to manage my health. 167 




• Dimension 4 (D4) Social health support. 169 
• Dimension 5 (D5) Assessment of health information. 170 
• Dimension 6 (D6) Ability to actively participate with health care 171 
providers. 172 
• Dimension 7 (D7) Navigation through the health system. 173 
• Dimension 8 (D8) Ability to find good health information. 174 
• Dimension 9 (D9) Understanding health information well enough to 175 
know what to do. 176 
The scores for dimensions 1 to 5 are set to four values (completely 177 
disagree/disagree/agree/strongly agree), and the scores for dimensions 6 to 9 are set 178 
to 5 values (cannot be done or always have difficulties/usually difficult/ Sometimes 179 
difficult/ usually have ease/ always have ease). According to the author's request, an 180 
independent score was established for each dimension. 13 181 
 182 
Sociodemographic variables were collected by means of a patient interview, while clinical 183 
variables and those referring to anticoagulant treatment with VKA were collected from the 184 
medical records and prescriptions. With regard to the health literacy variable, the 185 
questionnaire was administered to patients by means of a direct interview with the principal 186 
investigator. 187 
 188 
Statistical Analysis 189 
To analyse quantitative variables were used central tendency and dispersion measures. 190 
Absolute and relative frequencies, expressed in percentages, were used for qualitative 191 
variables. Parametric and non-parametric tests were performed to evaluate the relationship 192 




determined to be p <0.05. Were analysed all data using SPSS Statistics for Windows 194 
(version 23, Spanish, Armonk, NY, IBM). 195 
 196 
Ethical Considerations 197 
The study was approved by the Ethics and Clinical Research Committee of the Primary 198 
Care Region of Valencia (Ref.ACC-ACE-2016-01). All participants have provided their 199 
written consent to participate in the study and the data of the patients included in the study 200 
have been anonymized at all times. 201 
 202 
RESULTS 203 
Description of the Sample 204 
The response rate was 35% (252 patients responded to the questionnaire). The average age 205 
was 74.3 +/- 7.3 years, with ~90% over 65-years old. Forty-two percent were women, and 206 
74.9% had AF as primary diagnosis. With respect to their educational level, 50% of 207 
participants had basic studies, while 40.1% did not. Of the 252 participants, 49.2% had 208 
complications and 11.9% required hospital admission. (Table 1) 209 
 210 
Relationships between HL Dimensions and Variables 211 
The average score of the participants on each HL dimension was slightly higher than 212 
expected (average of the scale) in all dimensions (Table 2), but mainly in dimension D4. 213 
The relationship between the HL dimensions and the different study variables is presented 214 
in Tables 3 and 4. 215 
 216 




were statistically significant, indicating differences in scores between two or more of the 218 
study level groups. The results showed that D2, D3, D5, D6, D7, D8 and D9 had 219 
differences between the three study level groups. The "without studies" group obtained the 220 
lowest mean scores on all dimensions, in contrast to the "university education" group with 221 
higher means. 222 
 223 
For social class, all Kruskal-Wallis tests of the different HL dimensions were statistically 224 
significant (p < .05) implying differences in scores between two or more social class 225 
groups. Dimensions D5, D8 and D9, were explained by social class at 13%-17%, 226 
suggesting a large social class effect on these dimensions. D5 and D9 showed differences 227 
between all social class groups, with lower median scores for lower-class than middle-class 228 
participants. In turn, the median scores in the middle class group were lower than those 229 
obtained by participants from the higher socioeconomic stratum. 230 
For variables related to medication use, there were statistically significant differences for 231 
"reports taking acenocoumarol" in all HL dimensions and for "polypharmacy" in all 232 
dimensions except D1, D4 and D6 (Table 3). Non-polymedicated participants and those 233 
reporting treatment with VKA had higher mean scores on all dimensions. 234 
 235 
Regarding the control of acenocoumarol and frequency of controls, statistically 236 
significant differences were obtained in all dimensions of the questionnaire. In all cases, 237 
participants with good anticoagulant control and adequate frequency obtained higher 238 
averages than those without good control or suboptimal control frequency. Additionally, 239 
the analysis indicated a small effect for the control of acenocoumarol and the frequency of 240 
controls on D4 scores. An average effect on the D1 scores for VKA control and on the D1 241 




on the scores of the other HL dimensions for drug control and control frequency. (Table 4) 243 
 244 
In relation to cardiovascular disease risk factors, tobacco use and HBP showed no 245 
statistically significant differences (p > .05) on any dimension. In contrast, statistically 246 
significant differences in the D5, D8 and D9 dimensions were observed in obese 247 
participants, with lower mean scores for these participants. 248 
 249 
The occurrence of complications presented (p < .05) in the scores of all dimensions of the 250 
HL questionnaire. In all cases, the scores of patients without complications were higher 251 
(Table 4). The same was true for emergency department attendance in the previous 6 252 
months. In both cases, a very large effect size was shown in all HL dimensions except D1, 253 
D4 and D6. 254 
 255 
Finally, hospital admissions showed statistically significant differences (p < .05) in all 256 
dimensions for unscheduled hospitalizations in the previous 6 months, except in dimension 257 
D4. In all cases, the mean scores of patients with unscheduled hospital admissions were 258 
lower than in the rest of the patients. (Table 4) 259 
 260 
DISCUSSION 261 
In our study in patients with cardiovascular pathology, health literacy actively influenced 262 
the adequate self-management of anticoagulation treatment, the appearance of 263 
complications and the unscheduled use of health services. Patients with higher scores on 264 
HL dimensions had better control of OAC treatment and optimal frequency of visits. They 265 
also reported confidence about their information management skills, empowerment, and 266 




some authors.14-17  268 
 269 
Therapeutic concordance with OACs was significantly related to the scores of all HL 270 
dimensions, with 54.8% of participants presenting an adequate control of OAC treatment. 271 
These results are similar to another study carried out in Valencia,18 where 53.9% presented 272 
good control, and slightly higher than the 47.5% of patients in Time in Therapeutic Range 273 
(TTR) in Granada19. Reading et al.20 related inadequate HL to a lack of pharmacological 274 
adherence in AF, while another study associated a poor control of VKA (TTR<50%) with 275 
limited HL, especially in patients over 6521. However, other studies have reported 276 
equivocal relations between HL and treatment adherence; for example, HL as measured 277 
with the S-TOFHLA scale was associated with OAC treatment adherence but not with 278 
TTR22,23. A 2017 study24 using the SAHLPA scale linked inadequate level of HL to greater 279 
cognitive impairment and the need for help to take the treatment properly, but the 280 
multivariate analysis could not correlate an inadequate level of HL with having a TTR in 281 
the range. It is possible that these studies were unrelated because the scales were only used 282 
to evaluate recognition and ability to read certain words, not the different dimensions and 283 
skills that comprise HL. Because of this, patients may receive high scores in the scales yet 284 
lack more complex treatment-focused skills. 285 
 286 
With respect to the occurrence of complications associated with OAC treatment, our study 287 
showed a significant association with scores in all HL dimensions, with higher-scoring 288 
patients experiencing fewer complications, lower emergency department attendance and 289 
hospitalization rates. Complications occurred in 49.2% of participants (228 patients), well 290 
above the 9% shown in a 2014 study25. This difference could be due to the origin of the 291 




case, while the 2014 study25 used patient-reported complications which may have been 293 
affected by recall bias, particularly as the study noted that more than 50% of patients did 294 
not recognize emergency situations.  295 
 296 
Overall, such results may have been expected as HL dimensions allow people to identify 297 
reliable and accurate health information, resolve doubts on their own or with peer support 298 
and learn about preventive health services, anticipating and mitigating the occurrence of 299 
complications. This perspective is also supported by other authors who associate lower HL 300 
with a reduced awareness of AF diagnosis26, adherence to treatment20, higher rates of re-301 
hospitalization27, risk of mortality27-29 and a decrease in physical and emotional health 302 
status15. This study15 also uses the HLQ questionnaire but only evaluated two dimensions, 303 
"Understanding health information" and "Engaging with healthcare providers", and 304 
suggests that HL is also associated with health behaviours in cardiovascular patients.  305 
 306 
In addition to the above variables, a relationship between age, educational or academic 307 
level and social class was also observed with HL scores. Younger patients considered 308 
themselves capable of identifying accurate information from different sources, even on 309 
their own, remaining up-to-date and knowledgeable about health services. These results are 310 
consistent with other studies on patients with cardiovascular health problems, which 311 
negatively correlated the level of HL with the age of the participants.30-32 The powerful 312 
influence of ‘educational’ or academic factors on HL, explaining about 60% of the HL 313 
level31, as well as ‘social class’ has been extensively described14,33,34. These findings 314 






The health outcomes obtained in our study would align well with the WHO's social 318 
determinants model, which proposes the ‘social origin’ of diseases, in turn causing health 319 
inequalities. Within this framework, HL has shown its central role as a determinant of 320 
health35. In fact, low levels of education limit access to better jobs, or nudging persons 321 
towards less secure and riskier jobs, with lower incomes and poorer levels of health 322 
throughout life36,37. 323 
 324 
Our research has shown that different health determinants could contribute to inadequate 325 
control of anticoagulant therapy. Such determinants would be older age (over 75 years), 326 
basic or no education, limited HL (specifically the HL dimensions "Assessment of health 327 
information", "Ability to find good health information" and "Understanding health 328 
information sufficiently to know what to do"), low social class, obesity, multi-morbidity 329 
and polypharmacy. This finding allows an early identification of a profile of patients, more 330 
vulnerable, who would be most at risk of developing complications, having worse health 331 
outcomes. 332 
 333 
Further, our study is a pioneer in evaluating the nine dimensions that make up HL in 334 
patients on VKAs treatment (only one study has been found that evaluated the HL 335 
dimensions in this population and it only assesses two dimensions) and we noted the 336 
importance of the "social health support" dimension which showed a higher than expected 337 
average score. This dimension assesses a person’s social system and measures the 338 
following aspects: If I can get access to several people who understand and support me. If 339 
when I feel ill, the people around me really understand what I am going through. If I need 340 
help, I have plenty of people I can rely on. If I have at least one person who can come to 341 




In our study, this high score could be explained by the environment in which the study was 343 
carried out, a mainly rural área where inhabitants would benefit more from social support 344 
networks at neighbourhood and family level, less present or weaker in the urban 345 
environment, as shown in some studies carried out in Spain on patients with various 346 
pathologies.38,39 347 
 348 
In addition to the novel aspects discussed above, our work establishes a strong relationship 349 
between the dimensions of HL and the social determinants that constitute the axes of 350 
inequality in health. It highlights the importance of considering HL as a determinant of 351 
health because it is a predictor of individual health status and enables people in vulnerable 352 
situations to be identified and health inequalities to be addressed more effectively. 353 
 354 
For all these reasons, our study shows how HL intervenes in health behaviours and 355 
outcomes, modulating therapeutic concordance and the occurrence of complications in 356 
cardiovascular patients. Furthermore, taking into account the social determinants that 357 
influence HL, it would be appropriate to establish individual therapeutic measures and 358 
community interventions that act synergistically in HL to improve the prevention of 359 
cardiovascular disease. 360 
 361 
Limitations 362 
The study was conducted only in a rural population setting, using validated questionnaires 363 
for Spanish-speaking people. Routine objective variables have been collected and the 364 
sample size was calculated to reach a representative sample of the population. Although 365 
participation in the study and completion of the questionnaire was offered to all patients, 366 




could be interpreted as a selection bias. Furthermore, the study used a bivariate analysis 368 
model, so the results should be taken with caution because the statistical significance could 369 




The importance of the social environment in the health and safety outcomes of VKAs 374 
treatment is highlighted. People with higher scores on HL dimensions demonstrated better 375 
therapeutic control, lower emergency department attendance and fewer hospital admissions, 376 
highlighting the importance of intervening on this determinant because of its consequences 377 
on the control of patients with heart disease requiring VKAs treatment. 378 
 379 
LIST OF ABBREVIATIONS 380 
AF: Atrial fibrillation  381 
CFI: Comparative Fit Index  382 
DOACs: Direct Oral Anticoagulants 383 
D1: Dimension 1  384 
D2: Dimension 2  385 
D3: Dimension 3  386 
D4: Dimension 4  387 
D5: Dimension 5  388 
D6: Dimension 6  389 
D7: Dimension 7 390 
D8: Dimension 8  391 




HBP: High Blood Pressure 393 
HL: Health Literacy  394 
HLQ: Health Literacy Questionnaire  395 
INR: International Normalized Ratio  396 
OAC: Oral Anticoagulants 397 
RMSEA: Root Mean Square Error of Approximation  398 
SAHLPA: Short Assessment of Health Literacy in Portuguese-speaking Adults 399 
S-TOFHLA: Test of Functional Health Literacy in Adults 400 
TLI: Tucker Lewis Index  401 
TTR: Time in Therapeutic Range 402 
US: United States  403 
VKAs: Vitamin K antagonists 404 
WHO: World Health Organization 405 
WRMR: Weighted Root Mean Square Residual  406 
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Table 1. Characteristics of participants (n=252) 580 




 <65 years 26 10.3% 


















Basic Education        126 50.0% 









 Middle 206 81.7% 









Atrial Flutter 7 2.8% 
Aortic Prosthesis 33 13.1% 
Mitral Prosthesis 23 9.2% 
 
























Yes 124 49.2% 
 
Emergency 




























Yes 166 65.9% 

























Dimension 1 3.201 .027 .429 3.125 4.000 1.500 3.000 3.500 
Dimension 2 2.657 .033 .517 2.750 4.000 1.000 2.250 3.000 
Dimension 3 2.817 .032 .511 2.800 4.000 1.000 2.600 3.000 
Dimension 4 3.494 .028 .437 3.600 4.000 1.400 3.200 3.800 
Dimension 5 2.387 .043 .686 2.400 4.000 1.000 2.000 2.800 
Dimension 6 4.106 .038 .596 4.200 5.000 1.200 3.800 4.600 
Dimension 7 3.507 .041 .654 3.667 5.000 1.167 3.083 4.000 
Dimension 8 3.052 .054 .851 3.200 5.000 1.000 2.400 3.800 
Dimension 9 3.268 .055 .871 3.400 5.000 1.400 2.600 4.000 




Table 3. Relationship and statistical significance between variables and HL dimensions. 
  D1 D2 D3 D4 D5 D6 D7 D8 D9 
Age D Sig. .022 -.105 -.104 -.030 -.223** -.118 -.189* -.282** -.261** 
 
<65 years 
Mean (SD) 3.18 (0.4) 2.73 (0.47) 2.86 (0.58) 3.48 (0.33) 2.59 (0.78) 4.35 (0.49) 3.74 (0.58) 3.42 (0.76) 3.59 (0.85) 
Median (IQR) 3.13 (0.50) 2.75 (0.50) 3.00 (0.80) 3.40 (0.60) 2.60 (1.20) 4.40 (1.00) 3.83 (0.67) 3.50 (1.20) 3.80 (1.60) 
 
=>65 years                   
Mean (SD) 3.2 (0.43) 2.65 (0.52) 2.81 (0.5) 3.5 (0.45) 2.36 (0.67) 4.08 (0.6) 3.48 (0.66) 3.01 (0.85) 3.23 (0.87) 
Median (IQR) 3.13 (0.50) 2.75 (0.75) 2.80 (0.40) 3.60 (0.60) 2.40 (0.80) 4.20 (0.60) 3.50 (1.00) 3.00 (1.20) 3.40 (1.60) 
Sex A Sig. .496 .055  .298 .137 .096 .217 .142 028* .015* 
 
Woman 
Mean (SD) 3.18 (0.46) 2.58 (0.54) 2.78 (0.53) 3.44 (0.5) 2.3 (0.7) 4.05 (0.64) 3.44 (0.66) 2.92 (0.84) 3.11 (0.85) 
Median (IQR) 3.00 (0.50) 2.50 (0.75) 2.80 (0.40) 3.60 (0.60) 2.40 (1.00) 4.00 (1.00) 3.50 (1.00) 3.00 (1.40) 3.20 (1.40) 
 
Man 
Mean (SD) 3.22 (0.4) 2.71 (0.5) 2.85 (0.5) 3.53 (0.38) 2.45 (0.67) 4.15 (0.56) 3.56 (0.65) 3.15 (0.85) 3.38 (0.87) 
Median (IQR) 3.25 (0.50) 2.75 (0.75) 2.80 (0.60) 3.60 (0.40) 2.40 (0.80) 4.20 (0.80) 3.67 (0.83) 3.20 (1.20) 3.40 (1.40) 
Education Level B,C Sig. < .001** < .001** < .001** .016* < .001** < .001** < .001** < .001** < .001** 
 
Without Studies 
Mean (SD) 3.06 (0.4) 2.33 (0.43) 2.51 (0.45) 3.42 (0.41) 1.94 (0.54) 3.85 (0.60) 3.08 (0.54) 2.38 (0.57) 2.56 (0.58) 
Median (IQR) 3.00 (0.25) 2.25 (0.5) 2.60 (0.60) 3.60 (0.60) 2.00 (0.80) 4.00 (0.60) 3.17 (0.83) 2.40 (0.80) 2.40 (0.80) 
 
Basic Education 
Mean (SD) 3.28 (0.44) 2.83 (0.47) 2.96 (0.42) 3.52 (0.47) 2.58 (0.56) 4.23 (0.53) 3.72 (0.57) 3.39 (0.66) 3.62 (0.67) 
Median (IQR) 3.25 (0.50) 3.00 (0.5) 3.00 (0.40) 3.80 (0.40) 2.60 (0.60) 4.20 (0.60) 3.83 (0.50) 3.60 (1.00) 3.80 (0.60) 
 
Higher Education 
Mean (SD) 3.4 (0.36) 3.11 (0.32) 3.36 (0.39) 3.67 (0.26) 3.26 (0.56) 4.54 (0.49) 4.16 (0.42) 4.06 (0.63) 4.35 (0.49) 
Median (IQR) 3.25 (0.50) 3.00 (0.25) 3.20 (0.80) 3.80 (0.20) 3.20 (1.00) 4.60 (0.60) 4.00 (0.33) 4.00 (0.80) 4.40 (0.60) 
Social Class C       Sig. .019* < .001** < .001** .003* < .001** < .001** < .001** < .001** < .001** 
 
Low 
Mean (SD) 2.98 (0.44) 2.3 (0.39) 2.41 (0.53) 3.38 (0.39) 1.81 (0.55) 3.76 (0.56) 3.04 (0.58) 2.25 (0.64) 2.43 (0.61) 
Median (IQR) 3.00 (0.50) 2.25 (0.50) 2.4 (0.80) 3.40 (0.40) 1.80 (0.80) 3.80 (0.80) 3.00 (0.67) 2.20 (0.40) 2.20 (0.80) 
 
Middle 
Mean (SD) 3.23 (0.42) 2.71 (0.51) 2.87 (0.49) 3.5 (0.45) 2.45 (0.66) 4.15 (0.59) 3.56 (0.65) 3.14 (0.82) 3.35 (0.83) 
Median (IQR) 3.25 (0.50) 2.75 (0.75) 3.00 (0.60) 3.60 (0.60) 2.60 (0.80) 4.20 (0.80) 3.67 (0.83) 3.20 (1.20) 3.40 (1.40) 
 
High 
Mean (SD) 3.27 (0.33 2.77 (0.5) 3 (0.34) 3.72 (0.29) 2.88 (0.67) 4.34 (0.51) 3.91 (0.31) 3.66 (0.64) 4.10 (0.56) 
Median (IQR) 3.25 (0.50) 2.75 (0.25) 3.00 (0.20) 3.80 (0.0) 3.00 (0.40) 4.20 (0.60) 4.00 (0.17) 4.00 (0.80) 4.20 (0.20) 
Polypharmacy A Sig. .255 < .001** .005* .780 < .001** .367 .004* < .001** < .001** 
 
No 
Mean (SD) 3.24 (0.4) 2.82 (0.46) 2.94 (0.58) 3.48 (0.4) 2.62 (0.68) 4.15 (0.63) 3.67 (0.64) 3.4 (0.83) 3.58 (0.84) 
Median (IQR) 3.25 (0.50) 3.00 (0.50) 3.00 (0.40) 3.60 (0.60) 2.60 (0.60) 4.20 (0.80) 3.83 (0.50) 3.60 (1.20) 3.80 (1.00) 
 
Yes 
Mean (SD) 3.18 (0.44) 2.57 (0.53) 2.75 (0.46) 3.5 (0.46) 2.26 (0.66) 4.08 (0.58) 3.42 (0.65) 2.87 (0.81) 3.10 (0.84) 
Median (IQR) 3.00 (0.50) 2.50 (0.75) 2.80 (0.40) 3.60 (0.60) 2.40 (1.00) 4.10 (0.60) 3.33 (0.83) 2.80 (1.40) 3.10 (1.40) 
Obesity A Sig. .895 .288 .113 .525 .030* .318 .142 .030* .018* 
 
No 
Mean (SD) 3.2 (0.43) 2.69 (0.52) 2.86 (0.51) 3.48 (0.45) 2.46 (0.7) 4.14 (0.55) 3.56 (0.65) 3.15 (0.84) 3.38 (0.86) 
Median (IQR) 3.13 (0.50) 2.75 (0.75) 2.80 (0.60) 3.60 (0.60) 2.60 (1.00) 4.20 (0.80) 3.67 (0.83) 3.20 (1.30) 3.40 (1.30) 
 
Yes 
Mean (SD) 3.2 (0.42) 2.62 (0.52) 2.76 (0.51) 3.52 (0.41) 2.28 (0.65) 4.06 (0.66) 3.43 (0.66) 2.91 (0.86) 3.11 (0.86) 
Median (IQR) 3.13 (0.50) 2.50 (0.75) 2.80 (0.50) 3.60 (0.50) 2.40 (1.00) 4.20 (0.60) 3.50 (0.83) 3.00 (1.50) 3.20 (1.50) 





Table 4. Statistical relationship between variables related to the treatment of OACs and occurrence of complications with HL dimensions 
  D1 D2 D3 D4 D5 D6 D7 D8 D9 
Good VKAs control A Sig. < .001** < .001** < .001** .006* < .001** < .001** < .001** < .001** < .001** 
No Mean (SD) 3.06 (0.41) 2.37 (0.42) 2.54 (0.50) 3.41 (0.46) 2.02 (0.58) 3.86 (0.60) 3.13 (0.61) 2.45 (0.64) 2.64 (0.67) 
Yes Mean (SD) 3.31 (0.41) 2.89 (0.46) 3.04 (0.39) 3.56 (0.40) 2.68 (0.62) 4.30 (0.50) 3.81 (0.52) 3.54 (0.67) 3.77 (0.65) 
Adequate frequency A Sig. < .001** < .001** < .001** .001* < .001** < .001** < .001** < .001** < .001** 
No Mean (SD) 3.06 (0.37) 2.36 (0.40) 2.50 (0.48) 3.37 (0.45) 1.97 (0.60) 3.86 (0.60) 3.12 (0.61) 2.46 (0.66) 2.66 (0.71) 
Yes Mean (SD) 3.28 (0.44) 2.83 (0.50) 3.00 (0.42) 3.56 (0.41) 2.63 (0.60) 4.25 (0.54) 3.74 (0.56) 3.41 (0.74) 3.63 (0.74) 























No Mean (SD) 3.00 (0.46) 2.32 (0.56) 2.28 (0.53) 3.30 (0.37) 1.99 (0.68) 3.71 (0.70) 3.16 (0.55) 2.33 (0.74) 2.60 (0.88) 
Yes Mean (SD) 3.21 (0.41) 2.68 (0.49) 2.86 (0.46) 3.51 (0.43) 2.42 (0.67) 4.15 (0.56) 3.54 (0.63) 3.12 (0.82) 3.40 (0.83) 
Complications A Sig. < .001** < .001** < .001** .002* < .001** < .001** < .001** < .001** < .001** 
No  Mean (SD) 3.31 (0.40) 2.91 (0.44) 3.05 (0.40) 3.57 (0.37) 2.74 (0.59) 4.31 (0.51) 3.85 (0.54) 3.60 (0.66) 3.82 (0.63) 
Yes Mean (SD) 3.08 (0.41) 2.38 (0.44) 2.57 (0.49) 3.40 (0.48) 2.02 (0.57) 3.88 (0.59) 3.14 (0.55) 2.48 (0.61) 2.69 (0.68) 
Emergency assistance  A Sig. < .001** < .001** < .001** .002* < .001** < .001** < .001** < .001** < .001** 
No  Mean (SD) 3.31 (0.40) 2.91 (0.43) 3.04 (0.40) 3.57 (0.37) 2.74 (0.58) 4.31 (0.51) 3.85 (0.54) 3.60 (0.66) 3.83 (0.63) 
Yes  Mean (SD) 3.08 (0.42) 2.38 (0.44) 2.57 (0.49) 3.40 (0.48) 2.01 (0.57) 3.88 (0.60) 3.13 (0.54) 2.47 (0.60) 2.67 (0.67) 
Hospital admission A Sig. .001* < .001** < .001** .073 < .001** < .001** < .001** < .001** < .001** 
No Mean (SD) 3.23 (0.40) 2.70 (0.50) 2.86 (0.48) 3.51 (0.42) 2.44 (0.67) 4.16 (0.55) 3.57 (0.63) 3.15 (0.82) 3.36 (0.83) 
Yes Mean (SD) 2.95 (0.54) 2.31 (0.48) 2.43 (0.54) 3.36 (0.47) 1.92 (0.58) 3.68 (0.70) 3.03 (0.57) 2.28 (0.64) 2.52 (0.77) 
* p < .05; ** p < .001; A, T-Student tests ; B, Anova; C, Kruskal-Wallis; D, Mann-Whitney U 
 
